wal0921
mAbexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 31, 2023 (NCT05891366)
Timeline
Indications
Mechanism of action
PLAUR inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06466135 | Phase 2 | Jul 2, 2024 | Walden Biosciences |
| NCT05891366 | Phase 1 | May 31, 2023 | Walden Biosciences |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Walden Biosciences | For profit | 2 | 2 | 2 | 2023 |
1 organizations
Page 1 / 1